Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

PaperCitations, authors & open-access status

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,870 citations, 2018 year and bronze oa status.

1,870
Citations
2018
Year
bronze
OA Status

Related on ScholarIQ

Shahneen Sandhu
Author
New England Journal of Medicine
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Cutaneous Melanoma Detection and Management
Topic
Melanoma and MAPK Pathways
Topic
470M+ articles · free account